Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy

First-line treatments for lymphomas often include high doses of prednisolone, but the risks of new-onset diabetes mellitus (DM) or worsening of preexisting DM following treatment with cyclic high dose corticosteroids is unknown. This cohort study matched non-Hodgkin lymphoma (NHL) patients treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Baech, Joachim, Severinsen, Marianne Tang, Øvlisen, Andreas K., Frederiksen, Henrik, Vestergaard, Peter, Torp-Pedersen, Christian, Jørgensen, Judit, Clausen, Michael Roost, Poulsen, Christian B., Brown, Peter, Gang, Anne Ortved, Pedersen, Robert Schou, Ekström Smedby, Karin, Eloranta, Sandra, Jakobsen, Lasse Hjort, El-Galaly, Tarec Christoffer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636321/
https://www.ncbi.nlm.nih.gov/pubmed/35679481
http://dx.doi.org/10.1182/bloodadvances.2021006859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636321/
https://www.ncbi.nlm.nih.gov/pubmed/35679481
http://dx.doi.org/10.1182/bloodadvances.2021006859

Ejemplares similares